Information:
Error:
ID
16732
Description
Weekly Topotecan in Patients Treated for Metastatic Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00193167
Link
https://clinicaltrials.gov/show/NCT00193167
Keywords
Versions (1)
- 8/3/16 8/3/16 -
Uploaded on
August 3, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Colon Cancer NCT00193167
Eligibility Colon Cancer NCT00193167
- StudyEvent: Eligibility
Similar models
Eligibility Colon Cancer NCT00193167
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
criteria Fulfill
Item
to be included in this study, you must meet the following criteria:
boolean
C0243161 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,2])
Colorectal cancer metastatic
Item
metastatic colorectal cancer
boolean
C0948380 (UMLS CUI [1])
Prior Chemotherapy Quantity Neoplasm Metastasis
Item
one previous chemotherapy for metastatic disease
boolean
C1514457 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
Measurable Disease | Evaluable Disease
Item
measurable or evaluable disease
boolean
C1513041 (UMLS CUI [1])
C1516986 (UMLS CUI [2])
C1516986 (UMLS CUI [2])
Performance of activities of daily living Assisted Ability
Item
able to perform activities of daily living with assistance
boolean
C1821398 (UMLS CUI [1,1])
C1269765 (UMLS CUI [1,2])
C0085732 (UMLS CUI [1,3])
C1269765 (UMLS CUI [1,2])
C0085732 (UMLS CUI [1,3])
Bone Marrow function | Liver function | Renal function
Item
adequate bone marrow, liver, and kidney function
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
C0031843 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
Informed consent
Item
all patients must give written informed consent prior to study entry.
boolean
C0021430 (UMLS CUI [1])
Study Subject Participation Status
Item
you cannot participate in this study if any of the following apply to you:
boolean
C2348568 (UMLS CUI [1])
Brain Involvement | Meninges Involvement
Item
brain or meningeal involvement
boolean
C0006104 (UMLS CUI [1,1])
C1314939 (UMLS CUI [1,2])
C0025285 (UMLS CUI [2,1])
C1314939 (UMLS CUI [2,2])
C1314939 (UMLS CUI [1,2])
C0025285 (UMLS CUI [2,1])
C1314939 (UMLS CUI [2,2])
Communicable Diseases Serious | medical condition Serious
Item
serious active infection or underlying medical conditions
boolean
C0009450 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C3843040 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C0205404 (UMLS CUI [1,2])
C3843040 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
Neoplasms
Item
other active neoplasms are ineligible
boolean
C0027651 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnant or lactating
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Study Subject Participation Status
Item
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
boolean
C2348568 (UMLS CUI [1])